{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Subject(ID=70805L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Subject(ID=70805L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Subject"},"Meetings":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Meeting(ID=5201L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5201L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Meeting"},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5201L,Language='FR')/Sessions"}},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5201L,Language='FR')/Subjects"}},"ID":"5201","Language":"FR","MeetingNumber":11,"IdSession":5212,"SessionNumber":12,"SessionName":"Session de printemps 2026","Council":1,"CouncilName":"Conseil national","CouncilAbbreviation":"CN","Date":"\/Date(1773619200000)\/","Begin":"1430","Modified":"\/Date(1776247630025)\/","LegislativePeriodNumber":52,"PublicationStatus":"final","MeetingOrderText":"Onzi\u00e8me s\u00e9ance","SortOrder":11,"Location":"N"},"SubjectsBusiness":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267206,IdSubject=70805L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267206,IdSubject=70805L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.SubjectBusiness"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267206,IdSubject=70805L,Language='FR')/Subjects"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267206,IdSubject=70805L,Language='FR')/Businesses"}},"IdSubject":"70805","BusinessNumber":20267206,"Language":"FR","BusinessShortNumber":"26.7206","Title":"Effets secondaires des vaccins \u00e0 ARN messager. Production incontr\u00f4l\u00e9e de prot\u00e9ine spike ?","SortOrder":1,"PublishedNotes":null,"Modified":"\/Date(1773410898103)\/","TitleDE":"Fragestunde.\nFrage Vontobel Erich.\nNebenwirkungen\nvon modRNA-Impfstoffen.\nUnkontrollierbare\nSpike-Protein-Produktion?","TitleFR":"Heure des questions.\nQuestion Vontobel Erich.\nEffets secondaires\ndes vaccins \u00e0 ARN messager.\nProduction incontr\u00f4l\u00e9e\nde prot\u00e9ine spike ?","TitleIT":null}]},"Transcripts":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Transcript(ID=371759L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=371759L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Transcript"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=371759L,Language='FR')/Subjects"}},"MembersCouncil":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=371759L,Language='FR')/MembersCouncil"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=371759L,Language='FR')/Businesses"}},"ID":"371759","Language":"FR","IdSubject":"70805","VoteId":null,"PersonNumber":4238,"Type":1,"Text":"<pd_text><p>Die Produktion von Spike-Protein ist gering, lokal und zeitlich eng begrenzt. Die Partikel, welche die mRNA transportieren, bleiben[NB]gr\u00f6sstenteils an der Einstichstelle und in den lokalen Lymphknoten. Eine Nutzen-Risiko-Bewertung von Millionen von geimpften Personen zeigt generell keine signifikant erh\u00f6hten Risiken, die auf Fremdproteine zur\u00fcckzuf\u00fchren sind, die nicht an der lokalen Injektionsstelle hergestellt werden. Dieser Aspekt von Impfstoffen ist ebenfalls Gegenstand der Forschung, und neue Erkenntnisse auf diesem Gebiet werden von den Beh\u00f6rden aufmerksam und kontinuierlich verfolgt. Falls sich Hinweise auf noch nicht bekannte Risiken ergeben w\u00fcrden, w\u00fcrden Massnahmen getroffen. [PAGE 408] </p>\n</pd_text>","MeetingCouncilAbbreviation":"N","MeetingDate":"20260316","MeetingVerbalixOid":4144,"IdSession":"5212","SpeakerFirstName":"Elisabeth","SpeakerLastName":"Baume-Schneider","SpeakerFullName":"Baume-Schneider Elisabeth","SpeakerFunction":"BR-F","CouncilId":99,"CouncilName":"Conseil f\u00e9d\u00e9ral","CantonId":26,"CantonName":"Jura","CantonAbbreviation":"JU","ParlGroupName":null,"ParlGroupAbbreviation":null,"SortOrder":1,"Start":"\/Date(1773673236634)\/","End":"\/Date(1773673289168)\/","Function":"BR-F","DisplaySpeaker":true,"LanguageOfText":"DE","Modified":"\/Date(1790250099384)\/","StartTimeWithTimezone":"\/Date(1773673236633+0060)\/","EndTimeWithTimezone":"\/Date(1773673289167+0060)\/","VoteBusinessNumber":null,"VoteBusinessShortNumber":null,"VoteBusinessTitle":null}]},"ID":"70805","Language":"FR","IdMeeting":"5201","VerbalixOid":796893,"SortOrder":19,"Modified":"\/Date(1790250099379)\/"}}